5-Chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-N-((3S,4S)-4-(4-(trifluoromethyl)phenyl)piperidin-3-yl)furan-2-carboxamide (2R,3R)-2,3-Dihydroxysuccinate

ID: ALA4591854

Chembl Id: CHEMBL4591854

PubChem CID: 155568758

Max Phase: Preclinical

Molecular Formula: C25H25Cl2F3N4O8

Molecular Weight: 487.31

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1ncc(Cl)c1-c1cc(C(=O)N[C@@H]2CNCC[C@H]2c2ccc(C(F)(F)F)cc2)oc1Cl.O=C(O)[C@H](O)[C@@H](O)C(=O)O

Standard InChI:  InChI=1S/C21H19Cl2F3N4O2.C4H6O6/c1-30-18(15(22)9-28-30)14-8-17(32-19(14)23)20(31)29-16-10-27-7-6-13(16)11-2-4-12(5-3-11)21(24,25)26;5-1(3(7)8)2(6)4(9)10/h2-5,8-9,13,16,27H,6-7,10H2,1H3,(H,29,31);1-2,5-6H,(H,7,8)(H,9,10)/t13-,16+;1-,2-/m01/s1

Standard InChI Key:  LLSNFBIVFCQYNW-ITIQKRDRSA-N

Associated Targets(Human)

HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-8 (47708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AKT1 Tchem Serine/threonine-protein kinase AKT (9192 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 487.31Molecular Weight (Monoisotopic): 486.0837AlogP: 4.88#Rotatable Bonds: 4
Polar Surface Area: 72.09Molecular Species: BASEHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.60CX Basic pKa: 9.21CX LogP: 3.50CX LogD: 1.70
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.55Np Likeness Score: -0.92

References

1. Dong X, Zhan W, Zhao M, Che J, Dai X, Wu Y, Xu L, Zhou Y, Zhao Y, Tian T, Cheng G, Jin Z, Li J, Shao Y, He Q, Yang B, Weng Q, Hu Y..  (2019)  Discovery of 3,4,6-Trisubstituted Piperidine Derivatives as Orally Active, Low hERG Blocking Akt Inhibitors via Conformational Restriction and Structure-Based Design.,  62  (15): [PMID:31298542] [10.1021/acs.jmedchem.9b00891]

Source